Stockreport

Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company

VITAL THERAPIES  (VTL) 
Last vital therapies earnings: 8/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vitaltherapies.com/node/5806
PDF – Transaction Expected to Create NASDAQ-listed Biopharmaceutical Company Focused on Advancing Immunic‘s Compelling Pipeline of Clinical-Stage and Late Preclinical Assets [Read more]